Clinical characteristics of primary ALL samples studied
| Sample no. . | WBC . | Blast % . | Phenotype . | MLL +/− . |
|---|---|---|---|---|
| L1 | 85 | 83 | B cell | Present |
| L2 | 40.1 | 95 | Pre-B | Absent |
| L5 | 89 | 69 | Pre-B | Absent |
| L7 | 34.8 | 86 | Pre-B | Absent |
| L8 | >100 | >90 | Pre-B | Present |
| L9 | 130 | 78 | T | Absent |
| Sample no. . | WBC . | Blast % . | Phenotype . | MLL +/− . |
|---|---|---|---|---|
| L1 | 85 | 83 | B cell | Present |
| L2 | 40.1 | 95 | Pre-B | Absent |
| L5 | 89 | 69 | Pre-B | Absent |
| L7 | 34.8 | 86 | Pre-B | Absent |
| L8 | >100 | >90 | Pre-B | Present |
| L9 | 130 | 78 | T | Absent |